133 related articles for article (PubMed ID: 26964858)
21. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
De Paula D; Bentley MV; Mahato RI
RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
Kim SI; Shin D; Lee H; Ahn BY; Yoon Y; Kim M
J Hepatol; 2009 Mar; 50(3):479-88. PubMed ID: 19155084
[TBL] [Abstract][Full Text] [Related]
23. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
24. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
25. Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.
Huang Y; Lin D; Jiang Q; Zhang W; Guo S; Xiao P; Zheng S; Wang X; Chen H; Zhang HY; Deng L; Xing J; Du Q; Dong A; Liang Z
Biomaterials; 2012 Jun; 33(18):4653-64. PubMed ID: 22480869
[TBL] [Abstract][Full Text] [Related]
26. Physicochemical characterization of anionic lipid-based ternary siRNA complexes.
Kapoor M; Burgess DJ
Biochim Biophys Acta; 2012 Jul; 1818(7):1603-12. PubMed ID: 22465067
[TBL] [Abstract][Full Text] [Related]
27. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
[TBL] [Abstract][Full Text] [Related]
28. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
[TBL] [Abstract][Full Text] [Related]
29. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
30. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
31. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Fisch G; Dames S; Löffler K; Fechtner M; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Aug; 13(16):1222-34. PubMed ID: 16625243
[TBL] [Abstract][Full Text] [Related]
32. Novel endosomolytic poly(amido amine) polymer conjugates for systemic delivery of siRNA to hepatocytes in rodents and nonhuman primates.
Parmar RG; Poslusney M; Busuek M; Williams JM; Garbaccio R; Leander K; Walsh E; Howell B; Sepp-Lorenzino L; Riley S; Patel M; Kemp E; Latham A; Leone A; Soli E; Burke RS; Carr B; Colletti SL; Wang W
Bioconjug Chem; 2014 May; 25(5):896-906. PubMed ID: 24742200
[TBL] [Abstract][Full Text] [Related]
33. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the hepatic transcriptional landscape after RNAi mediated ApoB silencing in cynomolgus monkeys.
Hamza MS; Kumar C; Chia SM; Anandalakshmi V; Boo N; Strapps W; Robinson M; Caguyong M; Bartz S; Tadin-Strapps M; van Gool A; Shih SJ
Atherosclerosis; 2015 Oct; 242(2):383-95. PubMed ID: 26275376
[TBL] [Abstract][Full Text] [Related]
35. Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.
Sato Y; Hatakeyama H; Hyodo M; Harashima H
Mol Ther; 2016 Apr; 24(4):788-95. PubMed ID: 26678452
[TBL] [Abstract][Full Text] [Related]
36. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
37. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
38. Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.
Sarett SM; Werfel TA; Lee L; Jackson MA; Kilchrist KV; Brantley-Sieders D; Duvall CL
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6490-E6497. PubMed ID: 28739942
[TBL] [Abstract][Full Text] [Related]
39. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
40. Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex.
Jaiprasart P; Yeung BZ; Lu Z; Wientjes MG; Cui M; Hsieh CM; Woo S; Au JL
J Control Release; 2018 Jan; 270():101-113. PubMed ID: 29203416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
